APOTEX-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 1 mg tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

pramipexole dihydrochloride monohydrate, Quantity: 1 mg (Equivalent: pramipexole, Qty 0.7 mg)

Disponible desde:

Arrotex Pharmaceuticals Pty Ltd

Designación común internacional (DCI):

pramipexole dihydrochloride monohydrate

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: maize starch; magnesium stearate; microcrystalline cellulose

Vía de administración:

Oral

Unidades en paquete:

100

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

? Treatment of signs and symptoms of idiopathic Parkinson?s disease. It may be used as monotherapy or in combination with levodopa ? The symptomatic treatment of primary Restless Legs Syndrome.

Resumen del producto:

Visual Identification: White to off-white, round, flat-faced, beveled-edge tablet. Engraved "APO" on one side, "PR" over score "1" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Registered

Fecha de autorización:

2011-11-04